|
What is Orenitram?
|
|
Orenitram (treprostinil) is a prescription medicine used to treat pulmonary arterial hypertension (PAH) which is high blood pressure in the arteries of your lungs. Orenitram may improve your ability to exercise. It is not known if Orenitram is safe and effective in children under 18 years of age.
|
|
IMPORTANT SAFETY INFORMATION
|
FULL PRESCRIBING INFORMATION
|
PATIENT INFORMATION
|
|
CONSIDER TREATMENT
WITH ORENITRAM
|
|
Before you and your doctor decide which treatment is right for you, it’s a good idea to learn about your options. Have you checked out orenitram.com to learn about treatment with Orenitram and how it can fit into your daily routine? Orenitram was approved by the FDA in 2013 and is the oral form of the medicine treprostinil. Doctors have had over 10 years of clinical experience with treprostinil in other dosage forms.
|
|
|
|
|
How can Orenitram help you?
|
| It's helpful to consider the facts when you and your physician are deciding on your PAH treatment. |
| • |
In a large study, people who took Orenitram showed improvement in 6-minute walk distance compared with those receiving placebo.* That means Orenitram may help you improve your ability to do things like walking to the mailbox |
| • |
Orenitram is the tablet form of treprostinil. Treprostinil is also available in other dosage forms |
| • |
When you take Orenitram, you should know that you're not alone. The PEER Network offers you an opportunity to speak with others who are taking Orenitram |
|
|
|
*A 12-week study of 349 patients with PAH not currently receiving any other PAH therapy.
|
|
|
Do not take Orenitram if you have severe liver problems.
|
|
Before you take Orenitram, tell your healthcare provider if you:
|
- Have liver problems, diverticulosis, or any other medical conditions
- Are pregnant, breastfeeding, and/or plan to become pregnant or breastfeed. It is not known if Orenitram will harm your unborn baby or if Orenitram passes into your breast milk. You and your healthcare provider should decide if you will take Orenitram or breastfeed. You should not do both
|
|
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Orenitram and other medicines may affect each other causing side effects. Do not start or stop any new medicine until you check with your healthcare provider. Especially tell your healthcare provider if you take another medicine that contains the same ingredient, treprostinil. Know the medicines you take. Keep a list of them and the dose you take to show to your healthcare provider and pharmacist when you get a new medicine.
|
|
Do not change your dose or suddenly stop taking Orenitram without first talking to your healthcare provider. Stopping Orenitram suddenly may cause worsening of your PAH symptoms. If you miss two or more doses of Orenitram, call your healthcare provider. If you take too much Orenitram, call your healthcare provider or go to the nearest hospital emergency room right away.
|
|
If Orenitram tablets are not taken whole, they may release too much medicine at one time. This can lead to side effects.
Do not split, chew, crush, or break your Orenitram tablets. Do not take Orenitram tablets that are damaged or broken. Take Orenitram with food.
|
|
Orenitram can cause serious side effects, including an increased risk of bleeding. This risk could be increased if you are taking blood thinners such as warfarin.
|
|
The most common side effects of Orenitram include headache, diarrhea, nausea and flushing. These are not all of the possible side effects of Orenitram. Tell your doctor about any side effects that bother you, get worse over time, or do not go away.
|
|
OREISIdtcJAN16
|
|
|
You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.
|
|
Please see Full Prescribing Information and Patient Information.
|
|
For additional information about Orenitram, visit www.orenitram.com or call 1-877-UNITHER (1-877-864-8437).
|
|
This information is provided for an informational purpose and is not intended as treatment advice. Patients should consult a healthcare professional for treatment advice.
|
Orenitram is a registered trademark of United Therapeutics Corporation.
© 2018 United Therapeutics Corporation. All rights reserved. US/ORE/0238
|
|
Please do not reply, as this is an unattended email box.
|
If you do not wish to receive emails from the Orenitram Support Program, please click here or write to
Orenitram Support Program at PO Box 5279, Cary, NC 27512-9905.
|
|
55 T.W. Alexander Drive
PO Box 14186
Research Triangle Park, NC 27709
|
|
Orenitram.com
|
Privacy Policy
|
Terms of Use
|
|
This promotional communication is provided by United Therapeutics.
|
|